A multidisciplinary committee has been appointed to plan the Third International Summit on Human Genome Editing, which will take place March 7-9, 2022 in London, UK. The three-day Summit will be held at The Francis Crick Institute in London, with the option to participate remotely. The Summit is being organized by the UK Royal Society and Academy of Medical Sciences, the U.S. National Academy of Sciences and U.S. National Academy of Medicine, and UNESCO-The World Academy of Sciences for the advancement of science in developing countries (TWAS).
A statement from the presidents of the organizing institutions sets out how this Summit will build on previous events held in Washington, D.C. (2015), and Hong Kong (2018) and continue important international dialogue around human genome editing.
During the Summit, international stakeholders representing the academic, medical, regulatory, bioethical, and patient communities will discuss global considerations regarding human genome editing, including:
An update on advances in science and techniques in non-heritable and epigenetic genome editing since the 2018 Summit;
Current clinical research involving non-heritable genome editing and barriers to clinical applications;
The state of the science for germline genome editing in embryos and gametes;
Policy approaches to increase capacity and accessibility to treatments for genetic diseases globally;
Discussion of recent reports from the World Health Organization and potential methods for developing international and national regulatory frameworks;
Ethical, societal and cultural considerations surrounding human genome editing; and
The role of non-scientists, including the public, in setting the research agenda.
Further information and details on how to access the Summit will be released closer to the event. Sign up for our listserv to stay tuned!